1333 related articles for article (PubMed ID: 33210776)
1. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
[TBL] [Abstract][Full Text] [Related]
3. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
4. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
[TBL] [Abstract][Full Text] [Related]
5. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
[TBL] [Abstract][Full Text] [Related]
7. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
8. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
[TBL] [Abstract][Full Text] [Related]
9. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
[TBL] [Abstract][Full Text] [Related]
10. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
Araya-Rojas F; Lasso-Barreto M
Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
12. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
[TBL] [Abstract][Full Text] [Related]
14. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
[TBL] [Abstract][Full Text] [Related]
16. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
Sasoni N; Rodriguez Müller M; Posse G; González J; Leonardelli F; Garcia-Effron G
Rev Iberoam Micol; 2021; 38(1):16-18. PubMed ID: 33500209
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.
Paramythiotou E; Dimopoulos G; Koliakos N; Siopi M; Vourli S; Pournaras S; Meletiadis J
Infect Dis Ther; 2021 Sep; 10(3):1779-1792. PubMed ID: 34260038
[TBL] [Abstract][Full Text] [Related]
20. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]